LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 76.02 | 771.67 | 776 | 11106 | 0.0699 | 0.0015 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 78.25 | 771.67 | 1270 | 11367 | 0.1117 | 0.1370 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 78.25 | 771.67 | 755 | 11367 | 0.0664 | -0.0056 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 80.48 | 771.67 | 1336 | 11685 | 0.1143 | 0.1503 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 80.48 | 771.67 | 750 | 11685 | 0.0642 | -0.0072 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 82.69 | 771.67 | 1433 | 11974 | 0.1197 | 0.1694 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 82.69 | 771.67 | 726 | 11974 | 0.0606 | -0.0153 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 84.92 | 771.67 | 1523 | 12266 | 0.1242 | 0.1857 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 84.92 | 771.67 | 705 | 12266 | 0.0575 | -0.0224 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 87.14 | 771.67 | 1472 | 12592 | 0.1169 | 0.1739 | MN20160304_L01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 87.14 | 771.67 | 712 | 12592 | 0.0565 | -0.0198 | MN20160304_L01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 2.49 | 771.67 | 859 | 867 | 0.9899 | 0.8838 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 2.49 | 771.67 | 956 | 867 | 1.1017 | 2.5439 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 4.71 | 771.67 | 906 | 956 | 0.9473 | 0.6793 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 4.71 | 771.67 | 1030 | 956 | 1.0770 | 1.5414 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 6.94 | 771.67 | 944 | 1045 | 0.9032 | 0.5850 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 6.94 | 771.67 | 1081 | 1045 | 1.0343 | 1.1603 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 9.16 | 771.67 | 998 | 1138 | 0.8766 | 0.5815 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 9.16 | 771.67 | 1119 | 1138 | 0.9829 | 0.9394 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 11.56 | 771.67 | 1048 | 1280 | 0.8184 | 0.5202 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 11.56 | 771.67 | 1168 | 1280 | 0.9121 | 0.7633 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 13.78 | 771.67 | 1086 | 1459 | 0.7440 | 0.4500 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 13.78 | 771.67 | 1204 | 1459 | 0.8248 | 0.6221 | MN20160304_L01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.00 | 771.67 | 1126 | 1585 | 0.7102 | 0.4387 | MN20160304_L01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.00 | 771.67 | 1259 | 1585 | 0.7941 | 0.6019 | MN20160304_L01 | L09 |